Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Eisai Submits Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer's Disease in Great Britain
Eisai and Biogen announced today that Eisai has submitted a Marketing Authorization Application (MAA) for […]
Health Canada Accepts New Drug Submission for lecanemab as Treatment for Early Alzheimer's Disease
BioArctic AB’s partner Eisai announced today that Health Canada has accepted a New Drug Submission […]
Biologics License Application for Lecanemab Designated for Priority Review by China National Medical Products Administration
Eisai and Biogen announced today that the Biologics License Application (BLA) for lecanemab, an investigational […]
BioArctic: Lecanemab Receives Priority Review Status in Japan
BioArctic AB’s partner Eisai has announced that the application for manufacturing and marketing approval for […]
European Medicines Agency accepts Marketing Authorization Application for lecanemab as treatment for early Alzheimer's disease
BioArctic AB‘s partner Eisai have announced that the European Medicines Agency (EMA) has accepted a […]
Eisai Submits Marketing Application for lecanemab for Alzheimer's
BioArctic AB’s partner Eisai announced today that Eisai has submitted a marketing authorization application for […]
Eisai Submits Marketing Autherization Application for Lecanemab as Treatment for Early Alzheimer's Disease in Europe
Eisai and Biogen have announced that Eisai has submitted a marketing authorization application (MAA) for […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more